FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2973666279> ?p ?o ?g. }

• W2973666279 endingPage "557" @default.
• W2973666279 startingPage "557" @default.
• W2973666279 abstract "Pharmacognosy Magazine ,2019,15,65,557-567.DOI:10.4103/pm.pm_65_19Published:September 2019Type:Original Article Authors:De Ji, Jin-Chun Qiu, Xiao-Nan Su, Yu-Wen Qin, Min Hao, Lin Li, Tu-Lin Lu, Xiao-Kun Li, and Cheng-Xi Jiang Author(s) affiliations:De Ji1, Jin-Chun Qiu2, Xiao-Nan Su3, Yu-Wen Qin4, Min Hao3, Lin Li3, Tu-Lin Lu3, Xiao-Kun Li5, Cheng-Xi Jiang6 1Department of Chinese Medicinal Processing, School of Pharmacy, Nanjing University of Chinese Medicine; Molecular Pharmacology Research Center, School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, PR China 2Department of Pharmacy, Children's Hospital of Nanjing Medical University, Nanjing, PR China 3Department of Chinese Medicinal Processing, School of Pharmacy, Nanjing University of Chinese Medicine, Wenzhou, PR China 4Department of Chinese Medicinal Resources, Life Sciences Institute, Wenzhou University, Wenzhou, PR China 5Molecular Pharmacology Research Center, School of Pharmaceutical Science, Wenzhou Medical University; Department of Chinese Medicinal Resources, Biomedical Collaborative Innovation Center of Zhejiang, Wenzhou, PR China 6Department of Chinese Medicinal Resources, Life Sciences Institute, Wenzhou University; Department of Chinese Medicinal Resources, Biomedical Collaborative Innovation Center of Zhejiang, Wenzhou, PR China Abstract:Background: Anemarrhenae rhizoma (AR) is widely used for the treatment of febrile diseases, cough, and diabetes in traditional Chinese medicines. AR mainly contains flavonoids and steroidal saponins, such as neomangiferin, mangiferin, timosaponin BII, timosaponin BIII, and timosaponin AIII, which showed various biological activities. Objective: The main objective of the study is to establish an ultra-high-performance liquid chromatography-tandem mass spectrometry (MS/MS) method to determine the concentrations of five bioactive constituents in rats' plasma and various tissues. Materials and Methods: The analytes were separated on a C18reversed-phase column. A triple-quadrupole MS/MS equipped with an electrospray ionization source was used as a detector. The main pharmacokinetic parameters were estimated with Drug and Statistics 2.0 Software Package. Results: Neomangiferin and mangiferin exhibit poor oral absorption and slow clearance from the body. Timosaponin BII and timosaponin BIII could be quickly absorbed into the blood circulation and showed double plasma concentration peaks. Timosaponin AIII exhibited a single peak in the plasma concentration-time plot and pharmacokinetic parameters of timosaponin AIII indicated slower absorption, longer body residence time, and slower elimination than timosaponin BII and timosaponin BIII. The five analytes were widely distributed to most of the tissues. Neomangiferin and mangiferin exhibited the maximum concentration in the lung at 6 h after oral administration, the highest levels of timosaponin BII and timosaponin BIII were also observed in the lung at 1 h after oral administration, and the maximum concentration of timosaponin AIII was observed in the liver. Conclusion: The findings of the present study might be helpful to better understand the pharmacokinetics and distribution of AR bioactive constituents in vivo, which would facilitate the clinical application of AR. Keywords:Anemarrhenae rhizoma, herbal medicine, pharmacokinetics, tissue distribution, Traditional Chinese medicine, ultra-high-performance liquid chromatography-tandem mass spectrometryView:PDF (1.95 MB)" @default.
• W2973666279 created "2019-09-26" @default.
• W2973666279 creator A5005855810 @default.
• W2973666279 creator A5011623917 @default.
• W2973666279 creator A5014656305 @default.
• W2973666279 creator A5034321148 @default.
• W2973666279 creator A5037966774 @default.
• W2973666279 creator A5046091459 @default.
• W2973666279 creator A5047631234 @default.
• W2973666279 creator A5053764740 @default.
• W2973666279 creator A5064224780 @default.
• W2973666279 date "2019-01-01" @default.
• W2973666279 modified "2023-10-03" @default.
• W2973666279 title "Study on pharmacokinetics and tissues distribution of neomangiferin, mangiferin, timosaponin BII, Timosaponin BIII, and timosaponin AIII after oral administration of Anemarrhenae rhizoma extract in rats" @default.
• W2973666279 cites W1876525059 @default.
• W2973666279 cites W1969527544 @default.
• W2973666279 cites W1985520015 @default.
• W2973666279 cites W2002917161 @default.
• W2973666279 cites W2006090832 @default.
• W2973666279 cites W2009192664 @default.
• W2973666279 cites W2009811912 @default.
• W2973666279 cites W2010072104 @default.
• W2973666279 cites W2018358520 @default.
• W2973666279 cites W2024166950 @default.
• W2973666279 cites W2026443590 @default.
• W2973666279 cites W2040331070 @default.
• W2973666279 cites W2053740480 @default.
• W2973666279 cites W2055174762 @default.
• W2973666279 cites W2057080502 @default.
• W2973666279 cites W2061768810 @default.
• W2973666279 cites W2080821529 @default.
• W2973666279 cites W2092089201 @default.
• W2973666279 cites W2113302176 @default.
• W2973666279 cites W2115124273 @default.
• W2973666279 cites W2160188555 @default.
• W2973666279 cites W2286050557 @default.
• W2973666279 cites W2336511108 @default.
• W2973666279 cites W2397256171 @default.
• W2973666279 cites W2478285979 @default.
• W2973666279 cites W2573116415 @default.
• W2973666279 cites W2651958066 @default.
• W2973666279 cites W794253078 @default.
• W2973666279 cites W796496385 @default.
• W2973666279 doi "https://doi.org/10.4103/pm.pm_65_19" @default.
• W2973666279 hasPublicationYear "2019" @default.
• W2973666279 type Work @default.
• W2973666279 sameAs 2973666279 @default.
• W2973666279 citedByCount "5" @default.
• W2973666279 countsByYear W29736662792021 @default.
• W2973666279 countsByYear W29736662792023 @default.
• W2973666279 crossrefType "journal-article" @default.
• W2973666279 hasAuthorship W2973666279A5005855810 @default.
• W2973666279 hasAuthorship W2973666279A5011623917 @default.
• W2973666279 hasAuthorship W2973666279A5014656305 @default.
• W2973666279 hasAuthorship W2973666279A5034321148 @default.
• W2973666279 hasAuthorship W2973666279A5037966774 @default.
• W2973666279 hasAuthorship W2973666279A5046091459 @default.
• W2973666279 hasAuthorship W2973666279A5047631234 @default.
• W2973666279 hasAuthorship W2973666279A5053764740 @default.
• W2973666279 hasAuthorship W2973666279A5064224780 @default.
• W2973666279 hasConcept C104863432 @default.
• W2973666279 hasConcept C142724271 @default.
• W2973666279 hasConcept C166957645 @default.
• W2973666279 hasConcept C188947578 @default.
• W2973666279 hasConcept C191935318 @default.
• W2973666279 hasConcept C204787440 @default.
• W2973666279 hasConcept C205649164 @default.
• W2973666279 hasConcept C2777781930 @default.
• W2973666279 hasConcept C512399662 @default.
• W2973666279 hasConcept C556039675 @default.
• W2973666279 hasConcept C71924100 @default.
• W2973666279 hasConcept C98274493 @default.
• W2973666279 hasConceptScore W2973666279C104863432 @default.
• W2973666279 hasConceptScore W2973666279C142724271 @default.
• W2973666279 hasConceptScore W2973666279C166957645 @default.
• W2973666279 hasConceptScore W2973666279C188947578 @default.
• W2973666279 hasConceptScore W2973666279C191935318 @default.
• W2973666279 hasConceptScore W2973666279C204787440 @default.
• W2973666279 hasConceptScore W2973666279C205649164 @default.
• W2973666279 hasConceptScore W2973666279C2777781930 @default.
• W2973666279 hasConceptScore W2973666279C512399662 @default.
• W2973666279 hasConceptScore W2973666279C556039675 @default.
• W2973666279 hasConceptScore W2973666279C71924100 @default.
• W2973666279 hasConceptScore W2973666279C98274493 @default.
• W2973666279 hasIssue "65" @default.
• W2973666279 hasLocation W29736662791 @default.
• W2973666279 hasOpenAccess W2973666279 @default.
• W2973666279 hasPrimaryLocation W29736662791 @default.
• W2973666279 hasRelatedWork W1957284966 @default.
• W2973666279 hasRelatedWork W1993381463 @default.
• W2973666279 hasRelatedWork W2032763699 @default.
• W2973666279 hasRelatedWork W2328175912 @default.
• W2973666279 hasRelatedWork W2383196086 @default.
• W2973666279 hasRelatedWork W2755286099 @default.
• W2973666279 hasRelatedWork W2922344461 @default.
• W2973666279 hasRelatedWork W2923050913 @default.
• W2973666279 hasRelatedWork W2990325743 @default.
• W2973666279 hasRelatedWork W3110731682 @default.

• next